Article
17 December 2025 - by Jake K. Klaisner, Kali Schweitzer, Pepper Huang
We analyze hospital price transparency data to show variations in reimbursement for autoimmune drugs, with implications for patient access and affordability.
Article
24 July 2025 - by Kali Schweitzer, Brittany Schock
Continuous glucose monitoring holds significant promise for patients with type 2 diabetes who are not treated with insulin.
Article
13 May 2025 - by Michael T. Hunter, Kali Schweitzer, Jay Blomquist, Mat Khan, Pepper Huang
For some people with diabetes, hypertension, or hyperlipidemia, there’s a stronger relationship between medication adherence and lower healthcare costs for patients with high risk scores.
Article
06 March 2023 - by Ryan Cloninger, Kristin Niakan, Kali Schweitzer, Susan Silseth
A scenario analysis of the costs and timeline associated with elimination of hepatitis C virus in the United States.
Article
24 January 2023 - by Jessica Naber, Kristin Niakan, Kali Schweitzer, Jake K. Klaisner
Medicare FFS and Advantage show the highest rates of AIE prevalence of at least 8 per 100,000, more than double than that in the commercial channel.
Article
27 October 2022 - by Josh Collins, Kristin Niakan, Kali Schweitzer, Susan Silseth
Our study findings confirm that the COVID-19 pandemic had a negative impact on HIV testing, diagnosis, and treatment initiation metrics across the United States
Article
14 February 2022 - by Ali M. Heinrich, Kali Schweitzer
We discuss the controversy around the new drug Aduhelm, Medicare stakeholder considerations and impacts, and implications of CMS proposed coverage.
Article
04 February 2022 - by Jake K. Klaisner, Kali Schweitzer, AJ Ally
This report estimates the distribution of Myasthenia Gravis patients among Medicare Fee for Service, Medicare Advantage, Commercial, and Medicaid payer channels.
Article
22 September 2021 - by Madeleine Feller, Kali Schweitzer, Susan Silseth, Michelle Wang
Learn what the estimated costs are for the approved HCV treatment, interferon-free direct-acting antivirals.